Prospection
Prospection is an Australia-based SaaS provider of AI-powered patient-centric intelligence analytics for pharmaceutical and life sciences companies, transforming longitudinal claims data into patient journey insights and commercial decisioning across 100+ indications.
- Company typePrivate
- Founded2012
- HeadquartersDarlinghurst, Australia
- Headcount51–100
- GTM typeB2B
- OfferingSoftware
What Prospection does
Prospection is an Australian-headquartered healthcare data analytics company founded in 2012 that sells a SaaS platform called Prospection AI to pharmaceutical and life sciences enterprises. The platform applies a proprietary Patient-centric Intelligence (PCI) Core, built on a proprietary transformer architecture, to harmonize and analyze more than 80 billion clinical events and 500 million longitudinal patient journeys across 100+ indications and 20+ therapeutic areas, enabling customers to understand patient journeys, anticipate treatment decisions, and optimize commercial brand performance.
The product surface is structured as an integrated suite of modules: Prospection Insight for care-and-share leading indicators, Prospection Journey for treatment pattern and line-of-therapy analytics, Prospection Facility Insights for facility-level targeting, Prospection Predict for anticipatory trigger alerts, Critical Insights for KPI dashboards, and the award-winning ProGPT, a ChatGPT-powered conversational assistant that lets non-analyst brand teams query patient data in natural language. Prospection serves over 100 pharmaceutical companies, including multiple top-10 global pharma firms and named accounts such as Johnson & Johnson Innovative Medicine Asia Pacific, Otsuka, and Ipsen ANZ. Differentiated outcomes cited by the company include 15-20% improvement in targeting accuracy, 10-15% increase in commercial team productivity, 2-3x better prediction of market opportunities, and a 25% prescription lift in a facility-insights case study.
The company operates a direct enterprise field-sales motion with annual SaaS subscriptions priced by negotiation based on indication scope and data coverage, selling into brand managers, commercial leaders, and analytics professionals across the US, Japan, and Australia. Distribution is reinforced through executive roundtables co-hosted with hyperscalers such as Google and AWS, peer-reviewed real-world evidence publications, and APAC industry awards. The company has raised approximately $39.8M across multiple rounds, the largest being a ~$33.1M round led by Ellerston Capital in 2021, with strategic investment from Novotech Health Holdings in 2022, and is opening an Analytics Center of Excellence in India in 2024 to scale delivery capacity.
Prospection firmographics
Firmographics- Name
- Prospection
- Legal name
- Prospection
- Website
- https://prospection.com
- Company type
- Private
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Prospection is an Australia-based SaaS provider of AI-powered patient-centric intelligence analytics for pharmaceutical and life sciences companies, transforming longitudinal claims data into patient journey insights and commercial decisioning across 100+ indications.
- Ownership category
- akta.pro rank
Prospection industry classification
Industry- Product category
- Healthcare Analytics Software
- NAICS
- Other Computer Related Services (541519), Computer Systems Design Services (541512)
- SIC
- Services-Prepackaged Software (7372), Services-Computer Programming, Data Processing, Etc. (7370), Services-Computer Processing & Data Preparation (7374)
- akta.pro primary industry
- AI/ML Engineering & Model Development Services (BPAEAHAF)
Keywords
Where Prospection is headquartered
LocationHeadquarters
- HQ city
- Darlinghurst
- HQ country
- Australia
- HQ region
- Oceania
Offices2 records
Markets served
Prospection business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Infrastructure, Operations
Revenue model
- SaaS Platform Subscription: Prospection AI is a software-as-a-service (SaaS) offering that generates drug commercialization insights from patient-centric intelligence. The platform is sold as a subscription to pharmaceutical companies for brand management, commercial strategy, and patient journey analytics.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise SaaS subscription for pharmaceutical companies |
Go-to-market motion3 records
Distribution channels2 records
Marketing channels8 records
Prospection product offering
Product offeringCore offering
Prospection provides Prospection AI, a SaaS platform that transforms longitudinal patient-level claims and clinical data into patient-centric intelligence for pharmaceutical and life sciences companies. The platform combines proprietary transformer architecture (PCI Core) with machine learning and a generative AI assistant (ProGPT) to deliver patient journey analytics, facility-level profiling, predictive alerts, and brand performance insights across more than 100 indications and 20+ therapeutic areas.
Product overview
Prospection offers Prospection AI as its flagship integrated SaaS platform for pharmaceutical brand management. The platform combines a proprietary Patient-centric Intelligence Core with advanced AI/ML capabilities to transform longitudinal patient data into actionable insights. The platform includes multiple integrated modules: Insight (tracking care-and-share metrics), Journey (patient journey analysis), Facility Insights (account-level profiling), Predict (anticipatory alerts), ProGPT (conversational AI assistant), and Critical Insights (KPI dashboard). These modules work together as a unified system, with ProGPT serving as the natural language interface across all capabilities, enabling both analytics professionals and commercial brand teams to access patient-centric intelligence for drug commercialization decisions.
Differentiator
Problem solved
Functional benefit
Brands
- Prospection AI: Flagship SaaS platform for patient-centric intelligence that generates drug commercialization insights, incorporating ProGPT AI assistant.
- ProGPT
- Prospection Platform
- Facility Insights
- Prospection Insight
- Prospection Journey
- Prospection Predict
- Critical Insights
Products and services
- Prospection AI Platform Flagship SaaS platform serving as a pharma brand's single source for patient-centric intelligence; combines longitudinal patient data with proprietary AI/ML to power drug commercialization decisions across 100+ indications and 20+ therapeutic areas.
- Prospection Insight Tracks care-and-share metrics with patient-centric leading indicators, behavior insights, competitive intelligence, and product differentiation to guide pharmaceutical brand strategy.
- Prospection Journey Provides full understanding of complex patient journeys over time, including market share across lines of therapy, regimen nuances, and patient progression through diagnosis and treatment.
- Prospection Facility Insights Profiles healthcare accounts and optimizes resources with facility-level intelligence; combines sales data, hospital claims data, and proprietary datasets to understand treatment patterns at individual facilities.
- Prospection Predict Optimizes tactical execution with trigger alerts for events of interest, anticipating key moments in the patient journey including diagnosis, treatment initiation, switching, and discontinuation risk.
- ProGPT Award-winning GPT-powered AI assistant enabling brand teams to refine and explore insights via natural language chat, providing self-service analytics and hypothesis generation for routine brand management tasks.
- Critical Insights Provides answers to key business questions in a click, bringing insight into key performance indicators that complement brand plans and strategy through a user-friendly hub within the Prospection AI platform.
Quantifiable outcome
- 15-20% improvement in targeting accuracy for companies leveraging PCI
- +4 more outcomes
Companies that use Prospection
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles2 records
Prospection technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability6 records
Feature8 records
Prospection partnerships and signals
Strategic signalScale indicators13 records
Recent moves7 records
Expansion highlights6 records
Prospection competitors and assessment
Company assessmentBroad incumbents
- IQVIA: Global leader in healthcare data, analytics, and commercial services for life sciences. Overlaps directly with Prospection's pharma commercialization analytics, but operates at vastly larger scale across data, technology, and consulting services.
- Cerner / Oracle Health: Major EHR and healthcare data vendor with growing real-world data and analytics offerings for life sciences. Represents a large incumbent threat as it expands commercial analytics capabilities that overlap with Prospection's patient-centric intelligence platform.
Direct peers
- Veeva Systems: Cloud software platform serving pharmaceutical and life sciences companies with commercial, R&D, and data solutions. Veeva's commercial cloud and patient data offerings compete most directly with Prospection's drug commercialization platform for pharma brand teams.
- Komodo Health: Healthcare analytics company building a 'Healthcare Map' of de-identified patient encounters to power commercial insights and real-world evidence for pharma. Directly comparable to Prospection in patient journey analytics and pharma commercialization use cases.
- Definitive Healthcare: Provides commercial intelligence on healthcare providers, facilities, and activity for life sciences sales and marketing teams. Comparable to Prospection's Facility Insights in enabling pharma account-level targeting and resource allocation.
- Symphony Health (SymphonyAI): Combines longitudinal patient data, prescription, and claims analytics for pharma commercial teams. Directly competes in the patient-centric intelligence and real-world evidence space Prospection serves.
- Aetion: Real-world evidence analytics platform for biopharma, regulators, and payers. Comparable in serving pharma with longitudinal patient data analytics, though more focused on regulatory-grade evidence generation than commercial deployment.
- TriNetX: Global health research network providing real-world data and analytics for clinical research and real-world evidence. Overlaps with Prospection's patient journey analytics and the Novotech-partnered clinical trial use cases.
Emerging players
- Datavant: Healthcare data connectivity and de-identification platform that links disparate patient datasets. Adjacent to Prospection's data harmonization layer (PCI Core) and increasingly relevant as data linkage becomes critical for RWE platforms.
- COTA Healthcare: Real-world oncology and specialty disease data analytics company serving pharma with longitudinal patient insights. Comparable in using curated clinical data to drive pharma commercial decisions, though with narrower therapeutic focus.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Prospection social profiles
Digital presenceProspection compliance and trust
Trust signalCompliance1 record
Prospection financial estimates
Financial estimateRevenue estimate
Valuation estimate
Prospection leadership team
Management profileNumber of profiles
Profiles1 record
Prospection funding detail
Funding detailFunding overview
Funding rounds4 records
Investors5 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Prospection M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Prospection
What does Prospection do?
Prospection provides Prospection AI, a SaaS platform that transforms longitudinal patient-level claims and clinical data into patient-centric intelligence for pharmaceutical and life sciences companies. The platform combines proprietary transformer architecture (PCI Core) with machine learning and a generative AI assistant (ProGPT) to deliver patient journey analytics, facility-level profiling, predictive alerts, and brand performance insights across more than 100 indications and 20+ therapeutic areas.
Is Prospection a public or private company?
Prospection is a private company. It is classified as venture growth investor backed and is currently operating.
When was Prospection founded?
Prospection was founded in 2012. It employs 51 to 100 people.
Where is Prospection based?
Prospection is headquartered in Darlinghurst, Australia, in the Oceania region.
How does Prospection make money?
One revenue line is on record: saaS Platform Subscription.
Who are Prospection's main competitors?
Broad incumbents on record are IQVIA and Cerner / Oracle Health. Direct peers are Veeva Systems, Komodo Health, Definitive Healthcare, Symphony Health (SymphonyAI), Aetion and TriNetX. Emerging players are Datavant and COTA Healthcare.
Does Prospection have an API?
No public API is recorded for Prospection.
What industry is Prospection in?
Prospection's product category is Healthcare Analytics Software. Its primary akta.pro industry code is BPAEAHAF, AI/ML Engineering & Model Development Services. Its NAICS code is 541519 and its SIC code is 7372.